Literature DB >> 8587345

Stimulation and inhibition of neutrophil chemotaxis by endothelin-3.

J G Elferink1, B M de Koster.   

Abstract

Depending on the concentration, endothelin-3 (ET-3) has activating or inhibitory effects on neutrophil migration. At concentrations below 10 nM, neutrophil migration was stimulated by ET-3. The stimulating effect of ET-3 was mainly chemotactic, in contrast with that of ET-1, which was mainly chemokinetic. Concentrations of ET-3 lower than 10 nM potentiated chemotaxis activated by fMet-Leu-Phe (fMLP), whereas concentrations higher than 10 nM inhibited fMLP-activated neutrophil chemotaxis. The ETA receptor antagonist BQ123, the ET receptor agonist sarafotoxin S6c, and the ETB receptor antagonist IRL 1038 inhibited ET-3- and fMLP-activated migration. All of these compounds reversed the inhibitory effect of high concentrations of ET-3 on fMLP-activated chemotaxis. The results suggest that the ETA and the ETB receptor are both involved in the activating and inhibitory effects of ET-3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587345

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Association of endothelin with lung hemorrhage induced by immune complexes in rats.

Authors:  C F P Teixeira; S Jancar; W T Lima; P D'Orléans-Juste; P Sirois
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

2.  Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line.

Authors:  L Speciale; K Roda; M Saresella; D Taramelli; P Ferrante
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

3.  The endothelin B receptor plays a crucial role in the adhesion of neutrophils to the endothelium in sickle cell disease.

Authors:  Bérengère Koehl; Pierre Nivoit; Wassim El Nemer; Olivia Lenoir; Patricia Hermand; Catia Pereira; Valentine Brousse; Léa Guyonnet; Giulia Ghinatti; Malika Benkerrou; Yves Colin; Caroline Le Van Kim; Pierre-Louis Tharaux
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.